Loading clinical trials...
Loading clinical trials...
The primary objective is to obtain stool samples from subjects diagnosed with , and displaying signs and/or symptoms of IBD and/or IBS will be evaluated in this study. Eligible subjects require a diag...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
DiaSorin Inc.
NCT06372613 · Ulcerative Colitis in Histologic Remission
NCT07550673 · Acute Severe Ulcerative Colitis
NCT07374471 · Ulcerative Colitis (UC)
NCT06226883 · Inflammatory Bowel Diseases, Crohn's Disease
NCT05739864 · Active Ulcerative Colitis
One (1) Location in Dothan, Alabama
Dothan, Alabama
One (1) Facility in Arkansas
Little Rock, Arkansas
One (1) Location in California
Mission Hills, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions